Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v8-EN
Language French English
Date Updated 2021-06-16 2021-06-16
Drug Identification Number 02221861 02221861
Brand name ANANDRON ANANDRON
Common or Proper name NILUTAMIDE NILUTAMIDE
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients NILUTAMIDE NILUTAMIDE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister Pack (90 Tabs) Blister Pack (90 Tabs)
ATC code L02BB L02BB
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-04-30 2021-04-30
Actual start date
Estimated end date
Actual end date 2021-06-15 2021-06-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Manufacturing Delays Manufacturing Delays
Health Canada comments